NOVN bonds
Below is the list of NOVARTIS AG corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
UUS66989HAS7NOVARTIS CAP 20/50 | 6.97% | 0 | 61.50% | 2.75% | 2050-08-14 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNDNOVARTIS CAPITAL 15/45 | 6.09% | 0 | 81.01% | 4.00% | 2045-11-20 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | 6.01% | 4.91 M | 80.46% | 3.70% | 2042-09-21 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAW8NOVARTIS CAP 24/54 | 5.98% | 0 | 86.38% | 4.70% | 2054-09-18 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAH1NOVARTIS CAPITAL 14/44 | 5.92% | 0 | 86.45% | 4.40% | 2044-05-06 | 1.85 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNCNOVARTIS CAPITAL 15/25 | 4.71% | 0 | 99.42% | 3.00% | 2025-11-20 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAR9NOVARTIS CAP 20/30 | 4.61% | 0 | 90.06% | 2.20% | 2030-08-14 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAN8NOVARTIS CAPITAL 17/27 | 4.15% | 0 | 98.21% | 3.10% | 2027-05-17 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNFNOVARTIS CAP 20/27 | 4.14% | 0 | 96.82% | 2.00% | 2027-02-14 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXS176904119NOVARTIS FIN. 18/30 | 2.67% | 0 | 94.22% | 1.38% | 2030-08-14 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS149282548NOVARTIS FIN. 16/28 | 2.51% | 0 | 94.46% | 0.63% | 2028-09-20 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS113472979NOVARTIS FIN. 14/26 | 2.19% | 0 | 99.27% | 1.63% | 2026-11-09 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
NNOJANOVARTIS FIN. 17/27 | 2.16% | 0 | 97.81% | 1.13% | 2027-09-30 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
1.00% | 0 | 106.11% | 1.75% | 2034-06-16 | 645 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
0.99% | 0 | 106.22% | 1.75% | 2034-06-16 | 645 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
0.77% | 0 | 104.99% | 1.65% | 2031-06-18 | 435 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
0.67% | 0 | 99.80% | 0.63% | 2029-11-13 | 550 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
0.40% | 0 | 102.29% | 1.60% | 2027-06-18 | 650 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
0.40% | 0 | 102.29% | 1.60% | 2027-06-18 | 650 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |